Rates Of New ADRD Diagnosis Within 1 Year Of Entering Assisted Living Facilities: General Care Versus Memory Care
Gauri Gadkari, Cassandra Hua, Jennifer Bunker, Kali Thomas, Eric Jutkowitz

TL;DR
Residents in memory care-assisted living facilities are slightly more likely to receive a new dementia diagnosis within a year compared to general care facilities.
Contribution
This study compares new dementia diagnosis rates in memory care versus general care assisted living facilities using Medicare claims data.
Findings
10.9% of residents in general care ALs received a new ADRD diagnosis within a year.
11.7% of residents in memory care ALs received a new ADRD diagnosis within a year.
The difference in diagnosis rates was small but statistically significant.
Abstract
Assisted living (AL) is a growing option for long-term residential care among older adults. Some ALs hold specialized licenses to provide memory care (MC) and are better equipped to support residents experiencing cognitive decline, making them more likely to attract individuals anticipating such needs, regardless of their diagnosis status. Using Medicare claims, we identified beneficiaries who newly moved to ALs during 2020 and 2021 across 34 states with available MC licensure data. We examined rates of new Alzheimer’s disease and related dementias (ADRD) diagnoses within a year from entry into AL. Residents with an existing ADRD diagnosis (no MC: 24%, MC: 27%) were excluded, resulting in a final cohort of 95,207 beneficiaries. We fit logistic regression models to examine whether having MC licensure was associated with higher probability of new ADRD diagnoses. Risks were derived from…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGeriatric Care and Nursing Homes · Migration, Aging, and Tourism Studies · Dementia and Cognitive Impairment Research
